AzTrials
AzTrials

Virtual RealityVR effectNCT07300176

Virtual Reality-Assisted Intraoperative Sensory Modulation on Postpartum Depression and the Kynurenine Pathway

An observational study of Virtual Reality and Postpartum Depression (PPD), run by Duzce University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The research will be conducted as a prospective, observational, and comparative study with 98 pregnant volunteers aged 18-45 at Düzce University Faculty of Medicine. Participants will be divided into a VR group and a control group. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
How many people
98 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Nov 2025to 10 Mar 2026
How long will I take part?
6 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: The study population will consist of pregnant women scheduled for elective cesarean section under spinal anesthesia. Participants will be recruited from the obstetrics and gynecology department of the participating hospital. Eligible individuals must be between 18 and 45 years of age, carrying a singleton pregnancy, clinically stable for regional anesthesia and accepted for VR equipment usage during operation.

Who may be able to join

  • Pregnant women scheduled for elective cesarean section
  • Age between 18 and 45 years
  • ASA physical status I-II
  • No contraindication to spinal anesthesia
  • Accepted for VR equipment usage during operation.
  • Signed written informed consent

Who cannot join

  • Anticipated need for postoperative intensive care unit (ICU) admission
  • History of psychiatric or neurological disease
  • Visual or auditory impairment
  • Severe preeclampsia, eclampsia, or HELLP syndrome
  • Perinatal loss (postpartum neonatal death)
  • History of convulsions or epilepsy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Duzce University

    Düzce, 81620

Other trials in Turkey (Türkiye)

About this study

Official title: Observation of the Effects of Virtual Reality-Assisted Intraoperative Sensory Modulation on Postpartum Depression, Cognitive Function, and the Kynurenine Pathway

The research will be conducted as a prospective, observational, and comparative study with 98 pregnant volunteers aged 18-45 at Düzce University Faculty of Medicine. Participants will be divided into a VR group and a control group. Data will be collected using STAI-I, EPDS, NRS scales, and biochemical analyses (tryptophan, kynurenine, etc.).

Upon completion, the project is expected to contribute to non-pharmacological approaches and new care protocols for reducing postpartum depression.

Read the detailed description
  1. Ethics Approval, Study Design and Sample Size This study was conducted after obtaining approval from the Düzce University Non-Interventional Clinical Research Ethics Committee (Date: 10.11.2025, Decision No: 2025/285) and with the support of the Düzce University Scientific Research Projects (BAP) Coordination Unit (Project No: [Project Number]). The study was carried out in accordance with the principles of the Declaration of Helsinki. The research was planned as a prospective, observational study. It was conducted between October 2025 and August 2026 at Düzce University Health Application and Research Center in patients undergoing elective cesarean section. The sample size was calculated using the G*Power software (Version 3.1.9.4), based on an ANOVA for repeated measures with between-subjects factors. Assuming 80% power (1-β), a Type I error rate of 5% (α = 0.05) and a medium effect size (f = 0.25), the minimum required total sample size was calculated as 98 for two groups and two repeated measurements (postpartum week 1 and week 6 depression scores), corresponding to 49 participants per group. Written informed consent was obtained from all participants after they were given detailed information about the aim and procedures of the study. ________________________________________
  2. Study Population and Eligibility Criteria Inclusion criteria
  • Pregnant women scheduled for elective cesarean section
  • Age between 18 and 45 years
  • ASA physical status I-II
  • No contraindication to spinal anesthesia
  • Signed written informed consent Exclusion criteria
  • Anticipated need for postoperative intensive care unit (ICU) admission
  • History of psychiatric or neurological disease
  • Visual or auditory impairment
  • Severe preeclampsia, eclampsia, or HELLP syndrome
  • Perinatal loss (postpartum neonatal death)
  • History of convulsions or epilepsy
  1. Study Procedure and Grouping

A total of 98 patients who met the eligibility criteria were included and, in line with the observational design, were allocated into two groups:

  • Group 1 (VR group, n = 49): Patients who underwent cesarean section under spinal anesthesia and received intraoperative virtual reality (VR) intervention via a VR headset to provide sensory modulation.
  • Group 2 (Control group, n = 49): Patients who underwent cesarean section under spinal anesthesia and received standard clinical care without any VR application.

All patients underwent routine preoperative anesthetic evaluation in the anesthesia outpatient clinic. On the day of surgery, the State-Trait Anxiety Inventory-State form (STAI-I) was administered intraoperatively to assess anxiety levels.

In the operating room, after spinal anesthesia was performed and the sterile field was established, patients in Group 1 were fitted with a VR headset displaying preselected, nature-based, relaxation-oriented virtual reality content. The VR application was maintained continuously throughout the procedure until completion of skin closure, except for the moment of first maternal-infant contact. Patients in Group 2 received only standard clinical care and no VR headset was applied.

  • Data Collection Tools and Measurements Study data were collected using demographic information forms, validated psychometric scales, and biochemical analyses. 4.1. Anxiety Assessment Patients' state anxiety levels were assessed using the State-Trait Anxiety Inventory-State form (STAI-I), originally developed by Spielberger et al. (1970) and adapted and validated in Turkish by Öner and Le Compte (1983). This self-report instrument consists of 20 items that evaluate the individual's current emotional state and intensity of anxiety at the time of assessment. 4.2. Postpartum Depression Assessment Postpartum depression was screened using the 10-item Edinburgh Postnatal Depression Scale (EPDS), developed by Cox et al. (1987) and validated in Turkish by Engindeniz et al. (1996). The EPDS was administered at postpartum week 1 and week 6 to evaluate depressive symptoms. 4.3. Patient Satisfaction Assessment Patient satisfaction with the operative experience was evaluated at the end of surgery using a Numerical Rating Scale (NRS). The NRS is a commonly used instrument providing a numerical rating from 0 (not satisfied at all) to 10 (completely satisfied). 4.4. Biochemical Measurements For biochemical analyses, residual plasma samples obtained from routine preoperative and 24-hour postpartum blood tests were used. After collection, blood samples were centrifuged under appropriate conditions, and plasma aliquots were stored at -80°C until analysis. Plasma levels of kynurenine, kynurenic acid, tryptophan and quinolinic acid were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits, according to the manufacturer's instructions. ________________________________________
  • Statistical Analysis Statistical analyses were performed using IBM SPSS Statistics (Version XX, IBM Corp., Armonk, NY, USA). The normality of continuous variables was assessed using the Kolmogorov-Smirnov or Shapiro-Wilk tests, as appropriate. For between-group comparisons, the independent samples t-test was used for normally distributed continuous variables, and the Mann-Whitney U test for non-normally distributed variables. Categorical variables were compared using the chi-square test or Fisher's exact test when expected cell counts were small.

Within-group changes over time (preoperative vs. postpartum measurements) were analyzed using the paired samples t-test for normally distributed data or the Wilcoxon signed-rank test for non-normally distributed data. A two-sided p value < 0.05 was considered statistically significant for all analyses.

Keywords
Postpartum Depression, Kynurenine Pathway, Cesarean Section, Sensory Modulation, Virtual Reality
Medical subject headings
Depression, Postpartum, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07300176
Study groupRoleWhat they receive
Group 1 (VR group, n = 49):Patients who underwent cesarean section under spinal anesthesia and received intraoperative virtual reality (VR) intervention via a VR headset to provide sensory modulation.
Group 2 (Control group, n = 49)Patients who underwent cesarean section under spinal anesthesia and received standard clinical care without any VR application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Edinburgh Postnatal Depression Scale (EPDS)

    The Edinburgh Postnatal Depression Scale (EPDS) will assess depressive symptoms related to the peripartum period. Measurements will be obtained preoperatively and after the intraoperative VR application. Changes in EPDS scores (numbers 0-30 ) will help determine whether VR reduces depressive affect during the surgical experience.

    Measured: up to 6 weeks

  2. Change in State-Trait Anxiety Inventory-State (STAI-I) score

    The State-Trait Anxiety Inventory-State (STAI-I) score ( number 16-80) will be used to assess changes in acute anxiety levels in pregnant patients undergoing cesarean section under spinal anesthesia. Scores will be recorded immediately before the intraoperative VR intervention and again during the procedure. A reduction in STAI-I score following VR exposure will indicate decreased anxiety.

    Measured: up to 6 weeks

Secondary outcomes (2)
  1. Biochemical Levels of Kynurenine Pathway Metabolites

    Blood samples will be collected before the surgical procedure and postoperatively to quantify serum levels of key metabolites in kynurenine (ng/mL), kynurenic acid (ng/mL), tryptophan (ng/mL), and quinolinic acid (ng/mL) . Analytical methods (e.g., HPLC or LC-MS/MS) will be used to measure changes induced by the VR intervention. These biomarkers will help evaluate the physiological stress response and potential neuromodulatory effects of VR.

    Measured: up to 6 weeks

  2. Patient Satisfaction Numerical Rating Scale score

    Patient satisfaction will be assessed postoperatively using the Numerical Rating Scale (Number 0-10), where higher scores indicate greater satisfaction with the anesthesia and intraoperative experience. This secondary outcome evaluates whether VR improves overall comfort and satisfaction during spinal anesthesia for cesarean delivery.

    Measured: up to 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2025
  2. Study start10 Nov 2025
  3. Primary completion10 Mar 2026
  4. Study completion10 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
98 participants (actual)
Target duration
6 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT07300176
Sponsor's protocol ID
tufantez2025
Acronym
VR effect
Status last verified
Oct 2026
First submitted
10 Dec 2025
Last updated
20 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Virtual Reality and Postpartum Depression (PPD), run by Duzce University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Edinburgh Postnatal Depression Scale (EPDS) (time frame: up to 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in